Allergy and Infectious Diseases Research in Colorado
CFDA 93.855 — federal program obligations to Colorado
Total obligated
$493.0M
Awards
353
USAspending.gov records $475,768,789.60 in Allergy And Infectious Diseases Research obligations (CFDA 93.855) with place of performance in Colorado, across 339 awards. Three hundred thirty-nine instruments against $475.77 million imply about $1.40 million per award. This page joins NIAID catalog 93.855 to the CO geography tag. It is not a CDC investigation cell, not a lab census, and not cash already paid. Obligations are not outlays.
Key figures
- CFDA 93.855 shows $475,768,789.60 in Colorado obligations on 339 awards.
- The mean is about $1.40 million per award.
- The catalog is NIAID 93.855, not CDC investigations.
- Colorado is a place-of-performance tag, not a lab or PI census.
- Figures are obligations, not outlays.
Colorado crossed with CFDA 93.855
CFDA 93.855 is titled ALLERGY AND INFECTIOUS DISEASES RESEARCH. Crossed with Colorado place of performance, obligations sum to $475,768,789.60 on 339 awards. The national 93.855 hub includes other states. Colorado’s spending hub includes other programs. Only this intersection is reported here. $475,768,789.60 is an obligation aggregate from USAspending.gov, not an outlay and not a count of labs in Denver or Boulder.
Three hundred thirty-nine awards is a multi-project extramural pattern: NIAID assistance often posts as hundreds of discrete records rather than one statewide block. The join does not name recipients. Packet facts are $475,768,789.60, 339 awards, CO, and 93.855. Correlation is not causation. FEC donations do not fund this USAspending cell. Keep NIAID research and Colorado together when reading $475,768,789.60.
93.855 is not a CDC investigation catalog in Colorado
CDC investigation catalogs use different CFDA numbers. Mixing those series into $475,768,789.60 would invent a broader total than this cell contains. Facts available: Colorado, CFDA 93.855, $475,768,789.60, 339 awards. Study titles, activity codes, and publication counts are unpublished.
The catalog title names allergy and infectious diseases research, not a ranking of academic medical centers. Dividing $475,768,789.60 by 339 yields about $1.40 million per award. Unique recipients are unpublished. 339 is not a lab or PI census.
Full analysis: Allergy and infectious diseases research in Colorado →
Questions
- How much NIAID research is obligated in Colorado?
- USAspending records $475,768,789.60 in CFDA 93.855 obligations with Colorado place of performance on 339 awards. That is the pair total, not an outlay. Keep Allergy And Infectious Diseases Research and Colorado together when citing $475,768,789.60.
- Does 339 awards mean 339 Colorado laboratories?
- 339 is a USAspending award-record count, not a lab or PI census. The implied mean is about $1.40 million per award. Unique recipients are unpublished. 339 is a record count, not a person or facility census.
- Is this Colorado’s total federal research spending?
- No. This join is CFDA 93.855 only. Other NIH institute catalogs appear on separate Colorado program pages. Nationwide 93.855 is not limited to Colorado. Obligations of $475,768,789.60 are not outlays. The overlay is the live NIAID research–Colorado table.
- Do these obligations equal research completed?
- No. $475,768,789.60 is an obligation sum. Outlays are a different USAspending series. Drawdowns can lag the federal obligation. This packet has no outlay total. Original filings remain on USAspending.gov for this 93.855 × CO pair.
USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.
How this pair fits
Explore related views: National Allergy and Infectious Diseases Research profile · All programs in Colorado · All spending in Colorado